Startups
Myrobalan Therapeutics
Medford, Massachusetts biotechnology company developing brain-penetrant oral small-molecule therapies intended to address neuroinflammation and promote myelin repair. Founded by Jing Wang, Zhigang He and Guoping Feng, it pursues neurorestorative approaches for multiple sclerosis, ALS, Alzheimer's disease and other CNS conditions. Its investigational programs target CSF1R, GPR17 and TYK2, with biomarker-guided precision neurology supporting development.
Founded 2021
Team
 Ali FattaeyBoard Advisor |
Allison LiuClinical Advisor, Neuro-Ophthalmology |
Angela GengeClinical Advisor, ALS |
 Bin ChenBoard Member |
Brian PopkoScientific Advisor |
 Dan PasseriBoard Advisor |
 Ed WuHead of Medicinal Chemistry |
 Emma ReeveBoard Advisor |
Eric KlawiterClinical Advisor, Multiple Sclerosis and Neuromyelitis Optica |
 Frank WaligoraHead of CMC (Consultant) |
 Frank YanBoard Member |
Glenn YiuClinical Advisor, Neuro-ophthalmology |
 Grant BogleBoard Advisor |
 Guoping FengScientific Co-Founder · Board Member |
Heinz WiendlClinical Advisor, Multiple Sclerosis |
 James KupiecFractional Chief Medical Officer |
 Jing WangCo-Founder and Chief Executive Officer · Board Member |
Lee RubinScientific Advisor |
 Monica TommetFinance Director & Corporate Controller |
Pedro BrugarolasPET imaging advisor |
 Robin KleimanChief Scientific Officer |
 Stephen BoyerHead of Global Regulatory Strategy (Consultant) |
Susan GoelzBiomarker Advisor |
 Xin HuangBoard Member |
 Yibing ShanBoard Member |
 Zhigang HeScientific Co-Founder · Board Advisor |